Intrinsic value of Nutrisystem - NTRI

Previous Close

$51.80

  Intrinsic Value

$132.79

stock screener

  Rating & Target

str. buy

+156%

Previous close

$51.80

 
Intrinsic value

$132.79

 
Up/down potential

+156%

 
Rating

str. buy

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of NTRI stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 1.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  17.71
  30.00
  27.50
  25.25
  23.23
  21.40
  19.76
  18.29
  16.96
  15.76
  14.69
  13.72
  12.85
  12.06
  11.35
  10.72
  10.15
  9.63
  9.17
  8.75
  8.38
  8.04
  7.74
  7.46
  7.22
  6.99
  6.79
  6.62
  6.45
  6.31
  6.18
Revenue, $m
  545
  709
  903
  1,131
  1,394
  1,693
  2,027
  2,398
  2,804
  3,246
  3,723
  4,234
  4,778
  5,354
  5,962
  6,601
  7,271
  7,971
  8,702
  9,464
  10,256
  11,081
  11,938
  12,829
  13,755
  14,717
  15,717
  16,756
  17,838
  18,963
  20,134
Variable operating expenses, $m
 
  587
  749
  938
  1,156
  1,403
  1,680
  1,988
  2,325
  2,691
  3,086
  3,510
  3,961
  4,438
  4,942
  5,472
  6,027
  6,608
  7,214
  7,845
  8,503
  9,186
  9,897
  10,635
  11,403
  12,200
  13,029
  13,891
  14,787
  15,720
  16,691
Fixed operating expenses, $m
 
  41
  42
  43
  44
  45
  46
  48
  49
  50
  51
  52
  54
  55
  57
  58
  59
  61
  62
  64
  66
  67
  69
  71
  72
  74
  76
  78
  80
  82
  84
Total operating expenses, $m
  491
  628
  791
  981
  1,200
  1,448
  1,726
  2,036
  2,374
  2,741
  3,137
  3,562
  4,015
  4,493
  4,999
  5,530
  6,086
  6,669
  7,276
  7,909
  8,569
  9,253
  9,966
  10,706
  11,475
  12,274
  13,105
  13,969
  14,867
  15,802
  16,775
Operating income, $m
  54
  80
  112
  150
  194
  244
  300
  362
  431
  505
  585
  672
  763
  860
  963
  1,071
  1,184
  1,302
  1,426
  1,554
  1,688
  1,828
  1,973
  2,123
  2,280
  2,442
  2,612
  2,787
  2,970
  3,161
  3,359
EBITDA, $m
  68
  88
  122
  163
  210
  263
  323
  389
  462
  541
  626
  718
  816
  919
  1,029
  1,143
  1,264
  1,390
  1,521
  1,658
  1,801
  1,950
  2,104
  2,264
  2,431
  2,604
  2,784
  2,972
  3,167
  3,369
  3,581
Interest expense (income), $m
  0
  0
  1
  1
  2
  3
  4
  6
  7
  9
  10
  12
  14
  16
  18
  21
  23
  26
  28
  31
  34
  37
  40
  43
  47
  50
  54
  58
  61
  66
  70
Earnings before tax, $m
  54
  80
  112
  149
  192
  241
  296
  357
  424
  497
  575
  659
  749
  844
  945
  1,050
  1,161
  1,277
  1,397
  1,523
  1,654
  1,791
  1,933
  2,080
  2,233
  2,392
  2,558
  2,730
  2,909
  3,095
  3,289
Tax expense, $m
  19
  22
  30
  40
  52
  65
  80
  96
  114
  134
  155
  178
  202
  228
  255
  284
  313
  345
  377
  411
  447
  484
  522
  562
  603
  646
  691
  737
  785
  836
  888
Net income, $m
  35
  59
  82
  109
  140
  176
  216
  261
  309
  363
  420
  481
  547
  616
  690
  767
  847
  932
  1,020
  1,112
  1,208
  1,307
  1,411
  1,518
  1,630
  1,746
  1,867
  1,993
  2,124
  2,260
  2,401

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  154
  156
  199
  249
  307
  373
  446
  528
  617
  715
  820
  932
  1,052
  1,179
  1,313
  1,453
  1,601
  1,755
  1,916
  2,084
  2,258
  2,440
  2,628
  2,824
  3,028
  3,240
  3,460
  3,689
  3,927
  4,175
  4,433
Adjusted assets (=assets-cash), $m
  120
  156
  199
  249
  307
  373
  446
  528
  617
  715
  820
  932
  1,052
  1,179
  1,313
  1,453
  1,601
  1,755
  1,916
  2,084
  2,258
  2,440
  2,628
  2,824
  3,028
  3,240
  3,460
  3,689
  3,927
  4,175
  4,433
Revenue / Adjusted assets
  4.542
  4.545
  4.538
  4.542
  4.541
  4.539
  4.545
  4.542
  4.545
  4.540
  4.540
  4.543
  4.542
  4.541
  4.541
  4.543
  4.542
  4.542
  4.542
  4.541
  4.542
  4.541
  4.543
  4.543
  4.543
  4.542
  4.542
  4.542
  4.542
  4.542
  4.542
Average production assets, $m
  30
  39
  50
  62
  77
  93
  111
  132
  154
  179
  205
  233
  263
  294
  328
  363
  400
  438
  479
  520
  564
  609
  657
  706
  757
  809
  864
  922
  981
  1,043
  1,107
Working capital, $m
  42
  11
  14
  17
  21
  25
  30
  36
  42
  49
  56
  64
  72
  80
  89
  99
  109
  120
  131
  142
  154
  166
  179
  192
  206
  221
  236
  251
  268
  284
  302
Total debt, $m
  0
  18
  39
  64
  92
  124
  161
  201
  245
  293
  344
  400
  459
  521
  587
  656
  729
  804
  884
  966
  1,052
  1,141
  1,234
  1,331
  1,431
  1,535
  1,643
  1,756
  1,873
  1,995
  2,122
Total liabilities, $m
  60
  77
  98
  123
  151
  183
  220
  260
  304
  352
  403
  459
  518
  580
  646
  715
  788
  863
  943
  1,025
  1,111
  1,200
  1,293
  1,390
  1,490
  1,594
  1,702
  1,815
  1,932
  2,054
  2,181
Total equity, $m
  95
  79
  101
  127
  156
  189
  227
  268
  314
  363
  416
  474
  534
  599
  667
  738
  813
  892
  973
  1,058
  1,147
  1,239
  1,335
  1,435
  1,538
  1,646
  1,758
  1,874
  1,995
  2,121
  2,252
Total liabilities and equity, $m
  155
  156
  199
  250
  307
  372
  447
  528
  618
  715
  819
  933
  1,052
  1,179
  1,313
  1,453
  1,601
  1,755
  1,916
  2,083
  2,258
  2,439
  2,628
  2,825
  3,028
  3,240
  3,460
  3,689
  3,927
  4,175
  4,433
Debt-to-equity ratio
  0.000
  0.220
  0.380
  0.500
  0.590
  0.660
  0.710
  0.750
  0.780
  0.810
  0.830
  0.840
  0.860
  0.870
  0.880
  0.890
  0.900
  0.900
  0.910
  0.910
  0.920
  0.920
  0.920
  0.930
  0.930
  0.930
  0.930
  0.940
  0.940
  0.940
  0.940
Adjusted equity ratio
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508
  0.508

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  35
  59
  82
  109
  140
  176
  216
  261
  309
  363
  420
  481
  547
  616
  690
  767
  847
  932
  1,020
  1,112
  1,208
  1,307
  1,411
  1,518
  1,630
  1,746
  1,867
  1,993
  2,124
  2,260
  2,401
Depreciation, amort., depletion, $m
  14
  8
  10
  12
  15
  19
  22
  26
  31
  36
  41
  47
  53
  59
  66
  73
  80
  88
  96
  104
  113
  122
  131
  141
  151
  162
  173
  184
  196
  209
  221
Funds from operations, $m
  45
  66
  92
  121
  156
  195
  238
  287
  340
  398
  461
  528
  599
  675
  755
  839
  927
  1,020
  1,116
  1,216
  1,321
  1,429
  1,542
  1,659
  1,781
  1,908
  2,040
  2,177
  2,320
  2,468
  2,623
Change in working capital, $m
  -6
  2
  3
  3
  4
  4
  5
  6
  6
  7
  7
  8
  8
  9
  9
  10
  10
  11
  11
  11
  12
  12
  13
  13
  14
  14
  15
  16
  16
  17
  18
Cash from operations, $m
  51
  64
  89
  118
  152
  190
  233
  281
  334
  392
  454
  520
  591
  667
  746
  830
  917
  1,009
  1,105
  1,205
  1,309
  1,417
  1,529
  1,646
  1,768
  1,894
  2,025
  2,162
  2,303
  2,451
  2,605
Maintenance CAPEX, $m
  0
  -6
  -8
  -10
  -12
  -15
  -19
  -22
  -26
  -31
  -36
  -41
  -47
  -53
  -59
  -66
  -73
  -80
  -88
  -96
  -104
  -113
  -122
  -131
  -141
  -151
  -162
  -173
  -184
  -196
  -209
New CAPEX, $m
  -15
  -9
  -11
  -13
  -14
  -16
  -18
  -20
  -22
  -24
  -26
  -28
  -30
  -32
  -33
  -35
  -37
  -39
  -40
  -42
  -44
  -45
  -47
  -49
  -51
  -53
  -55
  -57
  -59
  -62
  -64
Cash from investing activities, $m
  -29
  -15
  -19
  -23
  -26
  -31
  -37
  -42
  -48
  -55
  -62
  -69
  -77
  -85
  -92
  -101
  -110
  -119
  -128
  -138
  -148
  -158
  -169
  -180
  -192
  -204
  -217
  -230
  -243
  -258
  -273
Free cash flow, $m
  22
  49
  70
  95
  125
  158
  196
  239
  285
  336
  392
  451
  515
  582
  654
  729
  808
  891
  977
  1,067
  1,161
  1,259
  1,360
  1,466
  1,576
  1,690
  1,808
  1,931
  2,060
  2,193
  2,332
Issuance/(repayment) of debt, $m
  0
  18
  21
  25
  28
  32
  36
  40
  44
  48
  52
  55
  59
  62
  66
  69
  73
  76
  79
  83
  86
  89
  93
  96
  100
  104
  108
  113
  117
  122
  127
Issuance/(repurchase) of shares, $m
  3
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  3
  18
  21
  25
  28
  32
  36
  40
  44
  48
  52
  55
  59
  62
  66
  69
  73
  76
  79
  83
  86
  89
  93
  96
  100
  104
  108
  113
  117
  122
  127
Total cash flow (excl. dividends), $m
  24
  67
  91
  120
  153
  191
  233
  279
  329
  384
  443
  507
  574
  645
  720
  798
  881
  967
  1,056
  1,150
  1,247
  1,348
  1,453
  1,562
  1,676
  1,794
  1,917
  2,044
  2,177
  2,315
  2,459
Retained Cash Flow (-), $m
  -25
  -18
  -22
  -26
  -29
  -33
  -37
  -41
  -45
  -49
  -53
  -57
  -61
  -64
  -68
  -71
  -75
  -78
  -82
  -85
  -89
  -92
  -96
  -100
  -104
  -108
  -112
  -116
  -121
  -126
  -131
Prev. year cash balance distribution, $m
 
  34
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  82
  69
  95
  124
  157
  195
  237
  284
  335
  390
  449
  513
  580
  652
  727
  806
  888
  974
  1,064
  1,158
  1,256
  1,357
  1,463
  1,572
  1,686
  1,805
  1,928
  2,056
  2,189
  2,328
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  79
  64
  82
  102
  122
  142
  160
  177
  192
  205
  213
  219
  221
  219
  213
  205
  193
  179
  164
  147
  130
  113
  96
  80
  66
  53
  41
  32
  24
  18
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Nutrisystem, Inc. is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company's program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy. Its customers order on an auto-delivery basis (Auto-Delivery), where means it sends a four-week meal plan on an ongoing basis until notified of a customer's cancellation. The Company offers its pre-selected favorites food pack or personalized plans, where customers can hand pick their entire menu or customize plans to their dietary preference. As of December 31, 2016, its meal plans featured over 150 menu options at different price points, including frozen and ready-to-go entrees, desserts, snacks and shakes.

FINANCIAL RATIOS  of  Nutrisystem (NTRI)

Valuation Ratios
P/E Ratio 43.9
Price to Sales 2.8
Price to Book 16.2
Price to Tangible Book
Price to Cash Flow 30.2
Price to Free Cash Flow 42.7
Growth Rates
Sales Growth Rate 17.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 15.4%
Cap. Spend. - 3 Yr. Gr. Rate 13.4%
Financial Strength
Quick Ratio NaN
Current Ratio 0.2
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 24.6%
Ret/ On Assets - 3 Yr. Avg. 21.4%
Return On Total Capital 42.4%
Ret/ On T. Cap. - 3 Yr. Avg. 39.6%
Return On Equity 42.4%
Return On Equity - 3 Yr. Avg. 39.6%
Asset Turnover 3.8
Profitability Ratios
Gross Margin 52.8%
Gross Margin - 3 Yr. Avg. 51.6%
EBITDA Margin 12.5%
EBITDA Margin - 3 Yr. Avg. 10.7%
Operating Margin 9.9%
Oper. Margin - 3 Yr. Avg. 8.6%
Pre-Tax Margin 9.9%
Pre-Tax Margin - 3 Yr. Avg. 8.6%
Net Profit Margin 6.4%
Net Profit Margin - 3 Yr. Avg. 5.6%
Effective Tax Rate 35.2%
Eff/ Tax Rate - 3 Yr. Avg. 34.9%
Payout Ratio 60%

NTRI stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the NTRI stock intrinsic value calculation we used $545 million for the last fiscal year's total revenue generated by Nutrisystem. The default revenue input number comes from 2016 income statement of Nutrisystem. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our NTRI stock valuation model: a) initial revenue growth rate of 30% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for NTRI is calculated based on our internal credit rating of Nutrisystem, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Nutrisystem.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of NTRI stock the variable cost ratio is equal to 82.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $40 million in the base year in the intrinsic value calculation for NTRI stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Nutrisystem.

Corporate tax rate of 27% is the nominal tax rate for Nutrisystem. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the NTRI stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for NTRI are equal to 5.5%.

Life of production assets of 2.1 years is the average useful life of capital assets used in Nutrisystem operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for NTRI is equal to 1.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $95 million for Nutrisystem - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 30.025 million for Nutrisystem is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Nutrisystem at the current share price and the inputted number of shares is $1.6 billion.

RELATED COMPANIES Price Int.Val. Rating
MED Medifast 72.88 37.80  sell
RGS Regis 15.98 12.54  hold
AMZN Amazon.com 1,162.00 534.47  sell
QVCA Liberty Intera 24.79 8.40  str.sell
WMT Wal-Mart Store 96.55 73.54  hold
SFLY Shutterfly 45.51 47.26  hold

COMPANY NEWS

▶ 3 Stocks To Buy On The Dip Right Now   [Nov-15-17 05:53PM  Zacks]
▶ 5 Stocks With Exciting Interest Coverage Ratio   [Nov-07-17 06:18AM  Zacks]
▶ Nutrisystem Earns Relative Strength Rating Upgrade; Hits Key Threshold   [Nov-03-17 03:00AM  Investor's Business Daily]
▶ Will Nutrisystem Incs (NTRI) Earnings Grow Over The Next Year?   [Oct-25-17 06:48PM  Simply Wall St.]
▶ Nutrisystem beats Street 3Q forecasts   [04:07PM  Associated Press]
▶ Nutrisystem, Inc. to Host Earnings Call   [08:10AM  ACCESSWIRE]
▶ This Top Growth Stock Near Buy Point With Q3 Earnings Due   [Oct-24-17 04:06PM  Investor's Business Daily]
▶ Stocks To Watch Ahead Of Earnings: Nutrisystem   [Oct-11-17 03:00AM  Investor's Business Daily]
▶ 5 Stocks With Exciting Interest Coverage Ratio   [Sep-18-17 10:14AM  Zacks]
▶ 3 Health Food Stocks to Buy Right Now   [Sep-07-17 06:51PM  Zacks]
▶ ETFs with exposure to Nutrisystem, Inc. : August 15, 2017   [Aug-15-17 04:42PM  Capital Cube]
▶ Behind the Turnaround at Nutrisystem   [12:21AM  The Wall Street Journal]
▶ What Consumer Data Has Taught Nutrisystem About Dieters   [Aug-11-17 10:24AM  The Wall Street Journal]
▶ Top Stock Picks for the Week of Aug 7, 2017   [Aug-08-17 03:54PM  Zacks]
▶ Stock Indexes Up, As Market Shows A Different Face   [Aug-04-17 12:06PM  Investor's Business Daily]
▶ Why Shares of NutriSystem Inc. Plunged 16% Today   [Jul-27-17 05:34PM  Motley Fool]
▶ Nutrisystem tops Street 2Q forecasts   [Jul-26-17 11:02PM  Associated Press]
▶ Whole Foods, Las Vegas Sands, Nutrisystem Earnings Top   [06:00PM  Investor's Business Daily]
▶ Time to Take Gains on Rising Nutrisystem Shares?   [Jun-19-17 07:02PM  Investopedia]
▶ Stocks Off, Banks Sink; Will These 4 Leaders Offer New Entries?   [May-31-17 03:00PM  Investor's Business Daily]
Financial statements of NTRI
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.